Eagle Veterinary Technology Co.Ltd (044960) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.011x

Based on the latest financial reports, Eagle Veterinary Technology Co.Ltd (044960) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-572.28 Million ≈ $-387.83K USD) by net assets (₩50.42 Billion ≈ $34.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 044960 equity to assets ratio to measure how much of total assets are equity-financed.

Eagle Veterinary Technology Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Eagle Veterinary Technology Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Eagle Veterinary Technology Co.Ltd (044960) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Eagle Veterinary Technology Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eagle Veterinary Technology Co.Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Aarvi Encon Limited
NSE:AARVI
0.045x
Galaxia SM Inc
KO:011420
0.082x
LakeShore Biopharma Co., Ltd
NASDAQ:LSB
-0.001x
Mawson Infrastructure Group Inc
NASDAQ:MIGI
1.112x
Powercom Co Ltd
TW:3043
-0.300x
Kurniamitra Duta Sentosa Tbk
JK:KMDS
0.002x
Murray International Trust
LSE:MYI
0.025x
FERRO-ALLOY RES.
F:5PE
N/A

Annual Cash Flow Conversion Efficiency for Eagle Veterinary Technology Co.Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Eagle Veterinary Technology Co.Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Eagle Veterinary Technology Co.Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩48.59 Billion
≈ $32.93 Million
₩4.34 Billion
≈ $2.94 Million
0.089x -17.31%
2023-12-31 ₩45.34 Billion
≈ $30.73 Million
₩4.89 Billion
≈ $3.32 Million
0.108x +1558.42%
2022-12-31 ₩42.95 Billion
≈ $29.11 Million
₩-317.89 Million
≈ $-215.43K
-0.007x -104.93%
2021-12-31 ₩40.83 Billion
≈ $27.67 Million
₩6.13 Billion
≈ $4.16 Million
0.150x -3.89%
2020-12-31 ₩37.74 Billion
≈ $25.57 Million
₩5.90 Billion
≈ $4.00 Million
0.156x +89.99%
2019-12-31 ₩35.53 Billion
≈ $24.08 Million
₩2.92 Billion
≈ $1.98 Million
0.082x +40.64%
2018-12-31 ₩34.55 Billion
≈ $23.41 Million
₩2.02 Billion
≈ $1.37 Million
0.058x +264.89%
2017-12-31 ₩31.91 Billion
≈ $21.63 Million
₩511.60 Million
≈ $346.70K
0.016x -83.77%
2016-12-31 ₩31.66 Billion
≈ $21.45 Million
₩3.13 Billion
≈ $2.12 Million
0.099x +420.08%
2015-12-31 ₩30.93 Billion
≈ $20.96 Million
₩-954.72 Million
≈ $-647.00K
-0.031x -148.03%
2014-12-31 ₩29.11 Billion
≈ $19.73 Million
₩1.87 Billion
≈ $1.27 Million
0.064x --

About Eagle Veterinary Technology Co.Ltd

KQ:044960 Korea Pharmaceuticals
Market Cap
$25.83 Million
₩38.12 Billion KRW
Market Cap Rank
#24248 Global
#1696 in Korea
Share Price
₩3015.00
Change (1 day)
+1.17%
52-Week Range
₩2765.00 - ₩4500.00
All Time High
₩11948.48
About

Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea. The company offers antibiotics, antibacterials, anthelmintics, antihistamins, and in the form of injectable, feed additives, oral liquids, and soluble powders for swine, poultry, and bovine. Eagle Veterinary Technology Co.,Ltd also exports its products to New Zealand, Australia, Vietnam, Kenya, … Read more